BIO Creating "Game-Changing" Legislative Proposal To Boost R&D
BIO's blueprint for an economic and regulatory environment that facilitates innovation in biotechnology and the industry's ability to bring products to market could be finished within a few months.
You may also be interested in...
FDA would no longer just be tasked with protecting public health but also with encouraging product development under ambitious legislative proposals that BIO is set to reveal.
BIO CEO Jim Greenwood is looking for "new big ideas" that would enable the pharmaceutical industry "to accelerate the pace of progress from academic research and translational research into products.
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.